IndraLab

Statements

Vemurafenib binds mutated BRAF. 2 / 2

| 2

➶

reach

"However, the mechanism of this selectivity is not clear since vemurafenib binds BRAF WT as well as BRAF mutants."

33568647

➶

reach

"The second article incorporated United States Food and Drug Administration-approved type 1.5 inhibitor vemurafenib, that binds BRAF as well as class 1, 2, and 3 BRAF mutants, into VHL-recruiting degrader SJF-0628 [3]."

35042023

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Vemurafenib binds mutated BRAF. 2 / 2

INDRA sources:

Databases

Reading